The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Hepatocyte Growth Factor-Global Market Insights and Sales Trends 2025
Synopsis
Hepatocyte growth factor (HGF) (or scatter factor (SF) is a paracrine cellular growth, motility and morphogenic factor. It is secreted by mesenchymal cells and targets and acts primarily upon epithelial cells and endothelial cells, but also acts on haemopoietic progenitor cells and T cells. It has been shown to have a major role in embryonic organ development, specifically in myogenesis, in adult organ regeneration, and in wound healing.
The global Hepatocyte Growth Factor market size is expected to reach US$ 287.9 million by 2029, growing at a CAGR of 30.0% from 2023 to 2029. The market is mainly driven by the significant applications of Hepatocyte Growth Factor in various end use industries. The expanding demands from the Oncology, Cardiovascular, Central Nervous System and Hematological Disorders, are propelling Hepatocyte Growth Factor market. Phase III (Ongoing), one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Phase II (Approved) segment is estimated at % CAGR for the next seven-year period.
Asia Pacific will be the largest region of Hepatocyte Growth Factor, which will occupy about 60% market share in 2030. North America will be the second largest market with the consumption market share of 25% in 2030. ViroMed, AnGes MG, M3 Biotechnology, AVEO Pharmaceuticals, Molecular Partners and Yooyoung Pharm are the major manufacturers of industry.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Hepatocyte Growth Factor, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Hepatocyte Growth Factor market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Hepatocyte Growth Factor market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Hepatocyte Growth Factor sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Hepatocyte Growth Factor covered in this report include ViroMed, AnGes MG, M3 Biotechnology, AVEO Pharmaceuticals, Molecular Partners, Yooyoung Pharm, F-star, Galaxy Biotech and Kringle Pharma, etc.
The global Hepatocyte Growth Factor market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
ViroMed
AnGes MG
M3 Biotechnology
AVEO Pharmaceuticals
Molecular Partners
Yooyoung Pharm
F-star
Galaxy Biotech
Kringle Pharma
Global Hepatocyte Growth Factor market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Hepatocyte Growth Factor market, Segment by Type:
Phase III (Ongoing)
Phase II (Approved)
Phase II (Ongoing)
Phase 1
Preclinical
Global Hepatocyte Growth Factor market, by Application
Oncology
Cardiovascular
Central Nervous System
Hematological Disorders
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Hepatocyte Growth Factor manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Hepatocyte Growth Factor in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Hepatocyte growth factor (HGF) (or scatter factor (SF) is a paracrine cellular growth, motility and morphogenic factor. It is secreted by mesenchymal cells and targets and acts primarily upon epithelial cells and endothelial cells, but also acts on haemopoietic progenitor cells and T cells. It has been shown to have a major role in embryonic organ development, specifically in myogenesis, in adult organ regeneration, and in wound healing.
The global Hepatocyte Growth Factor market size is expected to reach US$ 287.9 million by 2029, growing at a CAGR of 30.0% from 2023 to 2029. The market is mainly driven by the significant applications of Hepatocyte Growth Factor in various end use industries. The expanding demands from the Oncology, Cardiovascular, Central Nervous System and Hematological Disorders, are propelling Hepatocyte Growth Factor market. Phase III (Ongoing), one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Phase II (Approved) segment is estimated at % CAGR for the next seven-year period.
Asia Pacific will be the largest region of Hepatocyte Growth Factor, which will occupy about 60% market share in 2030. North America will be the second largest market with the consumption market share of 25% in 2030. ViroMed, AnGes MG, M3 Biotechnology, AVEO Pharmaceuticals, Molecular Partners and Yooyoung Pharm are the major manufacturers of industry.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Hepatocyte Growth Factor, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Hepatocyte Growth Factor market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Hepatocyte Growth Factor market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Hepatocyte Growth Factor sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Hepatocyte Growth Factor covered in this report include ViroMed, AnGes MG, M3 Biotechnology, AVEO Pharmaceuticals, Molecular Partners, Yooyoung Pharm, F-star, Galaxy Biotech and Kringle Pharma, etc.
The global Hepatocyte Growth Factor market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
ViroMed
AnGes MG
M3 Biotechnology
AVEO Pharmaceuticals
Molecular Partners
Yooyoung Pharm
F-star
Galaxy Biotech
Kringle Pharma
Global Hepatocyte Growth Factor market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Hepatocyte Growth Factor market, Segment by Type:
Phase III (Ongoing)
Phase II (Approved)
Phase II (Ongoing)
Phase 1
Preclinical
Global Hepatocyte Growth Factor market, by Application
Oncology
Cardiovascular
Central Nervous System
Hematological Disorders
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Hepatocyte Growth Factor manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Hepatocyte Growth Factor in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Hepatocyte Growth Factor Market Overview
1.1 Hepatocyte Growth Factor Product Overview
1.2 Hepatocyte Growth Factor Market Segment by Type
1.2.1 Phase III (Ongoing)
1.2.2 Phase II (Approved)
1.2.3 Phase II (Ongoing)
1.2.4 Phase 1
1.2.5 Preclinical
1.3 Global Hepatocyte Growth Factor Market Size by Type
1.3.1 Global Hepatocyte Growth Factor Market Size Overview by Type (2018-2029)
1.3.2 Global Hepatocyte Growth Factor Historic Market Size Review by Type (2018-2023)
1.3.3 Global Hepatocyte Growth Factor Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Hepatocyte Growth Factor Sales Breakdown by Type (2018-2023)
1.4.2 Europe Hepatocyte Growth Factor Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Hepatocyte Growth Factor Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Hepatocyte Growth Factor Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Hepatocyte Growth Factor Sales Breakdown by Type (2018-2023)
2 Global Hepatocyte Growth Factor Market Competition by Company
2.1 Global Top Players by Hepatocyte Growth Factor Sales (2018-2023)
2.2 Global Top Players by Hepatocyte Growth Factor Revenue (2018-2023)
2.3 Global Top Players by Hepatocyte Growth Factor Price (2018-2023)
2.4 Global Top Manufacturers Hepatocyte Growth Factor Manufacturing Base Distribution, Sales Area, Product Type
2.5 Hepatocyte Growth Factor Market Competitive Situation and Trends
2.5.1 Hepatocyte Growth Factor Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Hepatocyte Growth Factor Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Hepatocyte Growth Factor as of 2022)
2.7 Date of Key Manufacturers Enter into Hepatocyte Growth Factor Market
2.8 Key Manufacturers Hepatocyte Growth Factor Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Hepatocyte Growth Factor Status and Outlook by Region
3.1 Global Hepatocyte Growth Factor Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Hepatocyte Growth Factor Historic Market Size by Region
3.2.1 Global Hepatocyte Growth Factor Sales in Volume by Region (2018-2023)
3.2.2 Global Hepatocyte Growth Factor Sales in Value by Region (2018-2023)
3.2.3 Global Hepatocyte Growth Factor Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Hepatocyte Growth Factor Forecasted Market Size by Region
3.3.1 Global Hepatocyte Growth Factor Sales in Volume by Region (2024-2029)
3.3.2 Global Hepatocyte Growth Factor Sales in Value by Region (2024-2029)
3.3.3 Global Hepatocyte Growth Factor Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Hepatocyte Growth Factor by Application
4.1 Hepatocyte Growth Factor Market Segment by Application
4.1.1 Oncology
4.1.2 Cardiovascular
4.1.3 Central Nervous System
4.1.4 Hematological Disorders
4.1.5 Others
4.2 Global Hepatocyte Growth Factor Market Size by Application
4.2.1 Global Hepatocyte Growth Factor Market Size Overview by Application (2018-2029)
4.2.2 Global Hepatocyte Growth Factor Historic Market Size Review by Application (2018-2023)
4.2.3 Global Hepatocyte Growth Factor Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Hepatocyte Growth Factor Sales Breakdown by Application (2018-2023)
4.3.2 Europe Hepatocyte Growth Factor Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Hepatocyte Growth Factor Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Hepatocyte Growth Factor Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Hepatocyte Growth Factor Sales Breakdown by Application (2018-2023)
5 North America Hepatocyte Growth Factor by Country
5.1 North America Hepatocyte Growth Factor Historic Market Size by Country
5.1.1 North America Hepatocyte Growth Factor Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Hepatocyte Growth Factor Sales in Volume by Country (2018-2023)
5.1.3 North America Hepatocyte Growth Factor Sales in Value by Country (2018-2023)
5.2 North America Hepatocyte Growth Factor Forecasted Market Size by Country
5.2.1 North America Hepatocyte Growth Factor Sales in Volume by Country (2024-2029)
5.2.2 North America Hepatocyte Growth Factor Sales in Value by Country (2024-2029)
6 Europe Hepatocyte Growth Factor by Country
6.1 Europe Hepatocyte Growth Factor Historic Market Size by Country
6.1.1 Europe Hepatocyte Growth Factor Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Hepatocyte Growth Factor Sales in Volume by Country (2018-2023)
6.1.3 Europe Hepatocyte Growth Factor Sales in Value by Country (2018-2023)
6.2 Europe Hepatocyte Growth Factor Forecasted Market Size by Country
6.2.1 Europe Hepatocyte Growth Factor Sales in Volume by Country (2024-2029)
6.2.2 Europe Hepatocyte Growth Factor Sales in Value by Country (2024-2029)
7 Asia-Pacific Hepatocyte Growth Factor by Region
7.1 Asia-Pacific Hepatocyte Growth Factor Historic Market Size by Region
7.1.1 Asia-Pacific Hepatocyte Growth Factor Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Hepatocyte Growth Factor Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Hepatocyte Growth Factor Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Hepatocyte Growth Factor Forecasted Market Size by Region
7.2.1 Asia-Pacific Hepatocyte Growth Factor Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Hepatocyte Growth Factor Sales in Value by Region (2024-2029)
8 Latin America Hepatocyte Growth Factor by Country
8.1 Latin America Hepatocyte Growth Factor Historic Market Size by Country
8.1.1 Latin America Hepatocyte Growth Factor Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Hepatocyte Growth Factor Sales in Volume by Country (2018-2023)
8.1.3 Latin America Hepatocyte Growth Factor Sales in Value by Country (2018-2023)
8.2 Latin America Hepatocyte Growth Factor Forecasted Market Size by Country
8.2.1 Latin America Hepatocyte Growth Factor Sales in Volume by Country (2024-2029)
8.2.2 Latin America Hepatocyte Growth Factor Sales in Value by Country (2024-2029)
9 Middle East and Africa Hepatocyte Growth Factor by Country
9.1 Middle East and Africa Hepatocyte Growth Factor Historic Market Size by Country
9.1.1 Middle East and Africa Hepatocyte Growth Factor Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Hepatocyte Growth Factor Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Hepatocyte Growth Factor Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Hepatocyte Growth Factor Forecasted Market Size by Country
9.2.1 Middle East and Africa Hepatocyte Growth Factor Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Hepatocyte Growth Factor Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 ViroMed
10.1.1 ViroMed Company Information
10.1.2 ViroMed Introduction and Business Overview
10.1.3 ViroMed Hepatocyte Growth Factor Sales, Revenue and Gross Margin (2018-2023)
10.1.4 ViroMed Hepatocyte Growth Factor Products Offered
10.1.5 ViroMed Recent Development
10.2 AnGes MG
10.2.1 AnGes MG Company Information
10.2.2 AnGes MG Introduction and Business Overview
10.2.3 AnGes MG Hepatocyte Growth Factor Sales, Revenue and Gross Margin (2018-2023)
10.2.4 AnGes MG Hepatocyte Growth Factor Products Offered
10.2.5 AnGes MG Recent Development
10.3 M3 Biotechnology
10.3.1 M3 Biotechnology Company Information
10.3.2 M3 Biotechnology Introduction and Business Overview
10.3.3 M3 Biotechnology Hepatocyte Growth Factor Sales, Revenue and Gross Margin (2018-2023)
10.3.4 M3 Biotechnology Hepatocyte Growth Factor Products Offered
10.3.5 M3 Biotechnology Recent Development
10.4 AVEO Pharmaceuticals
10.4.1 AVEO Pharmaceuticals Company Information
10.4.2 AVEO Pharmaceuticals Introduction and Business Overview
10.4.3 AVEO Pharmaceuticals Hepatocyte Growth Factor Sales, Revenue and Gross Margin (2018-2023)
10.4.4 AVEO Pharmaceuticals Hepatocyte Growth Factor Products Offered
10.4.5 AVEO Pharmaceuticals Recent Development
10.5 Molecular Partners
10.5.1 Molecular Partners Company Information
10.5.2 Molecular Partners Introduction and Business Overview
10.5.3 Molecular Partners Hepatocyte Growth Factor Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Molecular Partners Hepatocyte Growth Factor Products Offered
10.5.5 Molecular Partners Recent Development
10.6 Yooyoung Pharm
10.6.1 Yooyoung Pharm Company Information
10.6.2 Yooyoung Pharm Introduction and Business Overview
10.6.3 Yooyoung Pharm Hepatocyte Growth Factor Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Yooyoung Pharm Hepatocyte Growth Factor Products Offered
10.6.5 Yooyoung Pharm Recent Development
10.7 F-star
10.7.1 F-star Company Information
10.7.2 F-star Introduction and Business Overview
10.7.3 F-star Hepatocyte Growth Factor Sales, Revenue and Gross Margin (2018-2023)
10.7.4 F-star Hepatocyte Growth Factor Products Offered
10.7.5 F-star Recent Development
10.8 Galaxy Biotech
10.8.1 Galaxy Biotech Company Information
10.8.2 Galaxy Biotech Introduction and Business Overview
10.8.3 Galaxy Biotech Hepatocyte Growth Factor Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Galaxy Biotech Hepatocyte Growth Factor Products Offered
10.8.5 Galaxy Biotech Recent Development
10.9 Kringle Pharma
10.9.1 Kringle Pharma Company Information
10.9.2 Kringle Pharma Introduction and Business Overview
10.9.3 Kringle Pharma Hepatocyte Growth Factor Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Kringle Pharma Hepatocyte Growth Factor Products Offered
10.9.5 Kringle Pharma Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Hepatocyte Growth Factor Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Hepatocyte Growth Factor Industrial Chain Analysis
11.4 Hepatocyte Growth Factor Market Dynamics
11.4.1 Hepatocyte Growth Factor Industry Trends
11.4.2 Hepatocyte Growth Factor Market Drivers
11.4.3 Hepatocyte Growth Factor Market Challenges
11.4.4 Hepatocyte Growth Factor Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Hepatocyte Growth Factor Distributors
12.3 Hepatocyte Growth Factor Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
